<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03242031</url>
  </required_header>
  <id_info>
    <org_study_id>CREUZOT PRME 2015</org_study_id>
    <nct_id>NCT03242031</nct_id>
  </id_info>
  <brief_title>Medico-economic Comparison Between Treatment With Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy</brief_title>
  <acronym>LIGHT</acronym>
  <official_title>Medico-economic Evaluation of Treatment With Panretinal Photocoagulation in One Session Using Multispot Laser Versus Four Sessions Using Single-spot Laser in Patients With Severe Non-proliferative and Early Proliferative Diabetic Retinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the fact that the efficacy of a single session of multispot laser has been
      demonstrated in the treatment of patients with diabetic retinopathy as compared with four
      sessions of single-spot laser, the management of panretinal photocoagulation in the different
      healthcare establishments in France has remained unchanged notably because there is no
      specific reimbursement for this new treatment protocol.

      Although the benefits of reducing the number of sessions and thus the costs associated with
      the treatment for the patient and the payer seem to be obvious, the medico-economic impact of
      modifying the treatment strategy thanks to the technological changes must be evaluated to
      provide deciders with additional information.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2017</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cost of treatment</measure>
    <time_frame>9 months after the start of treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>1 session</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>4 sessions</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>monospot panretinal photocoagulation</intervention_name>
    <description>panretinal photocoagulation with monospot laser</description>
    <arm_group_label>4 sessions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>multispot panretinal photocoagulation</intervention_name>
    <description>panretinal photocoagulation with multispot laser</description>
    <arm_group_label>1 session</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons who have provided written informed consent

          -  Patients with type 1 or 2 diabetes according to World Health Organisation diagnostic
             criteria.

          -  Patients with severe non proliferative or early proliferative diabetic retinopathy

          -  Visual acuity of the treated eye &gt;= 20/32 snellen (≥ 0.63 Monoyer units or ≥ 74
             letters Early treatment Diabetic Retinopathy Study)

          -  Visual acuity of the contralateral eye &gt;= 20/200 snellen (≥ 0.10 Monoyer units or ≥ 35
             letters Early treatment Diabetic Retinopathy Study)

          -  Patients with a central macular thickness of 350 μm or less on Spectral Domain -
             Optical Coherence Tomography

          -  Patients with national health insurance cover

          -  Patients over 18 years old

        Exclusion Criteria:

          -  Uncontrolled diabetes in the previous 6 months with intensive insulin therapy
             (glycated haemoglobin &gt; 11).

          -  Uncontrolled hypertension.

          -  Florid diabetic retinopathy floride.

          -  Macular oedema due to causes other than diabetic retinopathy or in a context of
             vitreomacular traction.

          -  History of intravitreal treatment with anti-angiogenic agent or corticosteroids within
             the 12 previous months.

          -  History of treatment with laser in panretinal photocoagulation or focal laser on the
             treated eye.

          -  History of eye surgery or laser capsulotomy within the previous 6 months

          -  History of renal failure requiring dialysis or kidney transplantation for diabetic
             nephropathy.

          -  Contra-indication for Tropicamide or Neo-synephrine

          -  History of uncontrolled glaucoma or hypertonia

          -  Patient with aphakia

          -  Adult under guardianship

          -  Pegnant or breast-feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Catherine CREUZOT GARCHER, MD</last_name>
    <phone>3.80.29.51.73</phone>
    <phone_ext>+33</phone_ext>
    <email>catherine.creuzot-garcher@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine CREUZOT GARCHER, MD</last_name>
      <phone>3.80.29.51.73</phone>
      <phone_ext>+33</phone_ext>
      <email>catherine.creuzot-garcher@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2017</study_first_submitted>
  <study_first_submitted_qc>August 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2017</study_first_posted>
  <last_update_submitted>August 23, 2017</last_update_submitted>
  <last_update_submitted_qc>August 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

